Beximco Pharmaceuticals Limited (BXP.L) LSE

42.50

+0(+0.00%)

Updated at December 24 09:11AM

Currency In GBp

Valuation

Market Cap25.87B
Enterprise Value31.04B
P/E Ratio6.29
PEG Ratio0.94
Price/Sales Ratio0.89
Price/Book Ratio0.63
Enterprise/Revenue1.02
Enterprise/EBITDA4.59

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.14
Operating Margin0.2

Management Effectiveness

Return On Assets0.07
Return On Equity0.1

Income Statement

Revenue44.39B
Revenue/Share79.25
Gross Profit19.63B
EBITDA10.64B
Net Income5.83B
Diluted EPS13.07

Balance Sheet

Total Cash2.36B
Total Cash/Share5.28
Total Debt6.19B
Total Debt/Equity0.12
Current Ratio2.13
Book Value Per Share120.21

Price History

52-Week Change14.86
52-Week High52.33
52-Week Low31.55
Moving Average 50 Days41.89
Moving Average 200 Days40.98

Statistics

Average Volume49,479
Shares Outstanding446.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor11:10
Last Split DateNovember 23, 2020